Scientists in India working to develop vaccine to combat Covid-19: Gadkari

The minister was addressing MSME and Infrastructure-Paving the growth path in Post-COVID World event

Nitin Gadkari
In India also a lot of institutions and scientists are working on the vaccine.
ANI New Delhi
2 min read Last Updated : Jun 16 2020 | 12:48 PM IST

Union Minister Nitin Gadkari has said that several Indian scientists and institutions are working to develop a vaccine to fight COVID-19.

"I have heard that a lot of experiments in the US have been successfully implemented. In India also a lot of institutions and scientists are working on it. We are waiting for the vaccine," he said while addressing MSME and Infrastructure-Paving the growth path in Post-COVID World event.

"At the same time, we are facing an economic war. Not only India but the whole world is facing this problem. I feel that the way in which the whole world now has a lot of reaction about China..the whole world is now interested to find out some new option for them," he added.

"I feel that India is definitely going to be a very good, viable option for all the investors in the world," Gadkari added.

Commenting upon the decision to hike the Minimum Support Price (MSP), Gadkari had stated "Union Cabinet under Prime Minister Narendra Modi's leadership had decided to hike MSP. I have not made any statements about decreasing MSP. This has been falsely attributed to me and I feel bad about it. Farmers should stay away from the wrong news. The Central government has always protected farmers and will continue doing so."

This comes in the backdrop of media reports quoting him that the government's minimum support prices for agriculture crops are way higher than domestic market prices and international rates which can create an "economic crisis" in the country.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusLockdownNitin Gadkari MSMECoronavirus Vaccine

First Published: Jun 16 2020 | 11:13 AM IST

Next Story